Influenza Vaccines: More Options and More Opportunities

Influenza vaccines: more options and more opportunities.

Influenza, whether seasonal or pandemic, causes substantial morbidity and mortality. Today, vaccines are the foundation of influenza prevention. Globally, influenza vaccine manufacturing capacity is at an all-time high [1], as are the number and types of influenza vaccines available on the market and in development. In the United States, in addition to the live attenuated and inactivated subuni...

Challenges and Perspectives toward Development of more Effective Influenza Vaccine

Influenza viruses continue to be a major health threat in human and bird populations. The improvements in formulation and production level of the current influenza vaccines are not sufficient to afford complete protection. The continuous antigenic drifts and emergence of endemic and zoonotic strains make influenza vaccine planning difficult. Concern about the emergence of new influenza pandemic...

More on Options Vs

How Can Vaccines Against Influenza and Other Viral Diseases Be Made More Effective?

1 Biological Mimetics, Inc., Frederick, Maryland, United States of America, 2 Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, United States of America, 3 Department of Veterinary Preventive Medicine and Microbiology, Iowa State University, Ames, Iowa, United States of America, 4 Department of Ecology and Evolutionary Biology, Princeton Unive...

New options for influenza vaccines: quadrivalent, recombinant, and cell culture.